Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children.
Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease.
For more information please visite www.novostia.com
Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease.
For more information please visite www.novostia.com
Location: Switzerland, Neuchâtel
Employees: 1-10
Total raised: $18.66M
Founded date: 2017
Funding Rounds 4
| Date | Series | Amount | Investors |
| 17.09.2024 | - | $6.63M | - |
| 03.05.2023 | Series A | $2.76M | - |
| 17.01.2020 | Grant | $2.77M | - |
| 22.02.2019 | - | $6.5M | - |
Mentions in press and media 11
| Date | Title | Description |
| 19.09.2024 | Novostia's Leap Forward: New Funding and Leadership in Medtech Innovation | In the heart of Lausanne, Switzerland, a medical technology revolution is brewing. Novostia, a promising startup, is making waves with its innovative artificial heart valve, the TRIFLO. This venture aims to change the lives of millions suff... |
| 19.09.2024 | Additional CHF 5.6 million and new leadership for Novostia | Based at Biopôle in Lausanne, Novostia is a medtech startup developing an innovative artificial heart valve, aiming to improve the quality of life of millions of patients worldwide suffering from aortic and mitral valve disease, while redu... |
| 17.09.2024 | Novostia Raises Additional CHF 5.6M in Funding | Novostia, a Lausanne, Switzerland-based medical technology company specializing in the development of a heart valve prosthesis, at clinical stage, closed a CHF 5.6m funding round. The backers were not disclosed. The company intends to use t... |
| 29.11.2023 | Swiss medtech startups enter next development phase | |
| 03.05.2023 | Novostia raises EUR 2.5M in Series A | |
| 10.09.2021 | First Biopôle Start-up Fund recipients announced | |
| 31.01.2020 | EIC Accelerator grants for Swiss startups | Launched in June 2019, the EIC Accelerator, previously known as SME Instrument, is for the first time offering “blended finance” in which startups and SMEs have the opportunity to receive both a grant and a direct equity investment. Through... |
| 31.01.2020 | EIC Accelerator grants for Swiss startups | |
| 22.02.2019 | Medtech start-up Novostia raises CHF 6.5 million | |
| 09.04.2018 | Bilan: 50 Startups to invest in |
Show more